Skip to main content
. 2023 Jun 6;18(8):2771–2784. doi: 10.1016/j.radcr.2023.05.024

Table 2.

Major symptom/sign (Group B).

Dysplastic/Multicystic kidney 29 (49,2%)
Renal agenesis 23 (39,0%)
Pelvic/abdominal cystic mass 3 (5,1%)
Renal agenesis + Cystic mass 2 (3,4%)
Dysplastic/Multicystic kidney + Cystic mass 1 (1,7%)
Pelvic kidney suspicion 1 (1,7%)